European Alliance for
Newborn Screening in Spinal Muscular Atrophy

Opening a new horizon
for children born with spinal muscular atrophy

SMA: Test at birth, save a life
Identifying children living with SMA through NBS allows for treatment to be started on time, preventing motor neuron death and a life with severe disabilities.

The European Alliance for Newborn Screening in Spinal Muscular Atrophy demands that by 2025, newborn screening programmes in all European countries include a test for spinal muscular atrophy for all newborn children.

Learn more about newborn screening for SMA in Europe

Find out more about the status of SMA screening in different countries

Tools

Download the latest versions of the SMA NBS Alliance materials

Get to know more about us

It’s time for Europe to bridge the gap in newborn screening for spinal muscular atrophy

• The European Alliance for Newborn Screening in Spinal Muscular Atrophy calls upon the government of Europe to include a test for spinal muscular atrophy in national newborn screening programmes.• Worldwide newborn screening projects and programmes for SMA clearly demonstrate that early detection and treatment of SMA prevents an early death or a life with […]

The European Alliance for Newborn Screening in Spinal Muscular Atrophy demands that by 2025, newborn screening programmes in all European countries include a test for spinal muscular atrophy for all newborn children.